Electronic cigarette user plasma nicotine concentration, puff topography, heart rate, and subjective effects: Influence of liquid nicotine concentration and user experience.
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Electronic cigarette (ECIG) nicotine delivery and other effects may depend on liquid nicotine concentration and user experience. This study is the first to systematically examine the influence of ECIG liquid nicotine concentration and user experience on nicotine delivery, heart rate, puff topography, and subjective effects. Thirty-three ECIG-experienced individuals and 31 ECIG-naïve cigarette smokers completed 4 laboratory conditions consisting of 2, 10-puff bouts (30-sec interpuff interval) with a 3.3-V ECIG battery attached to a 1.5-Ω "cartomizer" (7.3 W) filled with 1 ml ECIG liquid. Conditions differed by liquid nicotine concentration: 0, 8, 18, or 36 mg/ml. Participants' plasma nicotine concentration was directly related to liquid nicotine concentration and dependent on user experience, with significantly higher mean plasma nicotine increases observed in ECIG-experienced individuals relative to ECIG-naïve smokers in each active nicotine condition. When using 36 mg/ml, mean plasma nicotine increase for ECIG-experienced individuals was 17.9 ng/ml (SD = 17.2) and 6.9 (SD = 7.1; p < .05) for ECIG-naïve individuals. Between-group differences were likely due to longer puffs taken by experienced ECIG users: collapsed across condition, mean puff duration was 5.6 sec (SD = 3.0) for ECIG-experienced and 2.9 (SD = 1.5) for ECIG-naïve individuals. ECIG use also suppressed nicotine/tobacco abstinence symptoms in both groups; the magnitude of abstinence symptom suppression depended on liquid nicotine concentration and user experience. These and other recent results suggest that policies intended to limit ECIG nicotine delivery will need to account for factors in addition to liquid nicotine concentration (e.g., device power and user behavior). (PsycINFO Database Record
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 5×
“This conclusion is supported by the observation of similar FTND scores in experienced ECIG users relative to ECIG-naïve cigarette smokers, although scores were lower on the Penn State Dependence Index (see Table 1).”
BackgroundMethodInfluentialSigns and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
E-Cigarettes: A Scientific Review
Grana, R., Benowitz, N., & Glantz, S. A. (2014) · Circulation · doi:10.1161/circulationaha.114.007667 · Cited by 1,194
Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200020032051 · Cited by 1,188
Wagener, T. L., Floyd, E. L., Stepanov, I., Driskill, L. M., Frank, S. G., Meier, E., Leavens, E. L., Tackett, A. P., Molina, N., & Queimado, L. (2017) · Tobacco Control · doi:10.1136/tobaccocontrol-2016-053041 · Cited by 296 · cited 6×
“These nicotine delivery results are consistent with other studies that indicate that ECIGs can meet or exceed the nicotine delivery profile of combustible tobacco cigarettes (Dawkins et al., 2016; Spindle et al., 2017; Wagener et al., 2017).”
BackgroundResultInfluentialRamôa, C. P., Hiler, M. M., Spindle, T. R., Lopez, A. A., Karaoghlanian, N., Lipato, T., Breland, A. B., Shihadeh, A., & Eissenberg, T. (2016) · Tobacco Control · doi:10.1136/tobaccocontrol-2015-052447 · Cited by 157 · cited 2×
“…reports that examined the influence of liquid nicotine concentration on plasma nicotine concentration (Lopez, Hiler, Soule, et al., 2016; Ramôa et al., 2016) by increasing sample size, comparing across experienced ECIG users and ECIG-naïve cigarette smokers, and reporting on heart rate…”
BackgroundSelf-citationShould electronic cigarettes be as freely available as tobacco cigarettes? No
Chapman, S. (2013) · BMJ · doi:10.1136/bmj.f3840 · Cited by 75
Should electronic cigarettes be as freely available as tobacco? Yes
Etter, J.-F. (2013) · BMJ · doi:10.1136/bmj.f3845 · Cited by 62 · cited 2×
“…the factors that influence the subjective effects of ECIG-use will be important for understanding their abuse liability in general, and perhaps particularly important if ECIGs are to substitute completely for tobacco cigarettes among cigarette-smoking populations (e.g., Etter, 2013; Hajek, 2014).”
Background
Cited by
Soule, E. K., Lee, J. G. L., Egan, K. L., Bode, K. M., Desrosiers, A. C., Guy, M. C., Breland, A., & Fagan, P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107886 · Cited by 36
Self-citationGoldenson, N. I., Buchhalter, A. R., Augustson, E. M., Rubinstein, M. L., & Henningfield, J. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108395 · Cited by 30
Addicott, M. A., Sutfin, E. L., Reynolds, L. M., Donny, E. C., Matich, E. K., & Hsu, P.-C. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000604 · Cited by 10
Metadata
- Authors
- Hiler, M., Breland, A., Spindle, T., Maloney, S., Lipato, T., Karaoghlanian, N., Shihadeh, A., Lopez, A., Ramôa, C., & Eissenberg, T.
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2017-10
- Volume
- 25
- Issue
- 5
- Pages
- 380-392
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W2767108924
- Cited by
- 152
- References
- 8
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.